PPP1CB and Mycoplasma pneumoniae pneumonia: Reportedly, lung injury has been observed in mycoplasma pneumonia and is caused by an excessive immune-inflammatory response against Mp as glucocorticoid and immunoglobulin treatments remain efficacious against refractory mycoplasma pneumonia (Tamura et al., 2008; Shan et al., 2017).